The life sciences sector plays an important role in the UK economy with a turnover of £63.5 billion in 2016. It also has a critical role in providing new medicines and treatments that will improve patients’ lives.
More than 95% of companies in the sector are micro, small and medium-sized businesses, which often find it difficult to gain the real-world evidence they need to have their innovative technologies adopted.
This competition aims to help businesses gather that evidence.
Funding is for:
- smaller projects that develop plans for evidence-gathering in the NHS
- larger projects that collect clinical evidence on the performance and impact of a medicine or device in the NHS. Medical and diagnostic devices and digital health technologies must have a CE mark but must not have been marketed for more than 5 years
Projects should be able to show evidence of relevant discussions with organisations such as the National Institute for Health and Care Excellence and the NHS.
Projects should aim to address NHS priorities including to:
- reduce cancellations or unnecessary appointments
- reduce the burden on A&E services
- improve patient safety and avoid patient harm
- speed up diagnosis
- enable earlier diagnosis of cancer
- support management of long-term conditions, such as diabetes, chronic pain, cardiovascular disease, asthma and chronic obstructive pulmonary disease